Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
10.63
+0.63 (6.30%)
At close: Nov 7, 2025, 4:00 PM EST
10.58
-0.05 (-0.47%)
After-hours: Nov 7, 2025, 7:14 PM EST
Arvinas Market Cap
Arvinas has a market cap or net worth of $682.7 million as of November 7, 2025. Its market cap has decreased by -62.50% in one year.
Market Cap
682.70M
Enterprise Value
-95.60M
1-Year Change
-62.50%
Ranking
Category
Stock Price
$10.63
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $682.70M, an increase of 32.27%. That is a compound annual growth rate of 4.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 682.70M | -48.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | 4.09B | 159.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |